0.5mg

Molecular Formula : C33H21D4F3O4

Molecular Formula : C15 D4 H14 F2 N6 O7 S2

Molecular Formula : C1013C2H6F2N2O2

Molecular Formula : C8¹³C6H13F4N3O2S

Molecular Formula : C26H27D6FO7

Molecular Formula : C20H25FINO2

Molecular Formula : C43 H51 F5 O8 S

Molecular Formula : 13C5 C14 H19 N7 O6

Molecular Formula : C19 2H4 H15 N7 O6

Molecular Formula : C42H40D12N4O12

Molecular Formula : C8 H15 N2 O9 P

Molecular Formula : C32H44D3F5O3S

Molecular Formula : C34 H59 N O14

Molecular Formula : C31H42D6O6

Molecular Formula : C18 H29 N O3

Molecular Formula : C9 H11 D6 N O2 . H Cl

Molecular Formula : C15H19N3O7

Molecular Formula : C15H26O

Molecular Formula : 13C6 H6 Cl6

Molecular Formula : C21H44F2N5O13P3

Molecular Formula : C813CH12ClF2N15N2O4

Molecular Formula : C21H24D6O9

The GenCRISPR™
SaCas9 2NLS Nuclease can be formed with the guide RNA into a ribonucleoprotien
(RNP) complex. The use of an RNP complex to perform gene editing has been shown
to reduce the challenges encountered with other CRISPR gene editing techniques
such as viral and plasmid delivery. Challenges include off-target effects, cell
viability and transcription/translational challenges. The SaCas9 recognizes an
NNGRRT protospacer adjacent motif (PAM) and cleaves target DNA at high
efficiency with a variety of guide RNA (gRNA) spacer lengths.

GenCRISPR™ SaCas9 2NLS
Nuclease is a tag free nuclease produced by expression in an E. coli strain carrying a plasmid
encoding the Cas9 gene from Staphylococcus
aureus with a nuclear localization signal at both N-terminal and C-terminal.The
small size of the nuclease facilitates enhanced in vivo delivery for genome
editing in various organisms.

The GenCRISPR™
Ultra eSpCas9 product line provides customers with a selection of research use,
basic GMP and GMP compliant Cas9 nucleases. The Cas9 protein can be formed with
the guide RNA into a ribonucleoprotien (RNP) complex. The use of an RNP complex
to perform gene editing has been shown to reduce the challenges encountered
with other CRISPR gene editing techniques such as viral and plasmid delivery.
Challenges include off-target effects, cell viability and transcription/translational
challenges.

GenCRISPR™
Ultra eSpCas9-2NLS is a mutant form of Cas9 nuclease and is produced by
expression in an E. coli strain
carrying a plasmid encoding the eSpCas9 gene from Streptococcus pyogenes with double-ended nuclear localization
signal (NLS). GenCRISPR™ Ultra eSpCas9-2NLS delivers higher fidelity and less
off-target activity than wild-type SpCas9 nuclease.

The GenCRISPR™
Ultra eSpCas9 product line provides customers with a selection of research use,
basic GMP and GMP compliant Cas9 nucleases. The Cas9 protein can be formed with
the guide RNA into a ribonucleoprotien (RNP) complex. The use of an RNP complex
to perform gene editing has been shown to reduce the challenges encountered
with other CRISPR gene editing techniques such as viral and plasmid delivery.
Challenges include off-target effects, cell viability and transcription/translational
challenges.

GenCRISPR™ Ultra eSpCas9-N-NLS
Research, tag-free is a mutant form of Cas9
nuclease and is produced by expression in an E. coli strain carrying a plasmid encoding the eSpCas9 gene from Streptococcus pyogenes with an N-terminal
nuclear localization signal (N-NLS). GenCRISPR™ Ultra eSpCas9-N-NLS Research,
tag-free delivers higher fidelity
and less off-target activity than wild-type SpCas9 nuclease.

The
GenCRISPR™ Ultra Cas9 product line provides customers with a selection of
research use, GMP preclinical and GMP compliant Cas9 nucleases. The Cas9
protein can be formed with the guide RNA into a ribonucleoprotien (RNP)
complex. The use of an RNP complex to perform gene editing has been shown to
reduce the challenges encountered with other CRISPR gene editing techniques
such as viral and plasmid delivery. Challenges include off-target effects, cell
viability and trascprition/translational challenges.

GenCRISPR™ Ultra Cas9 is
produced by expression in an E. coli
strain carrying a plasmid encoding the Cas9 gene from Streptococcus pyogenes with an N-terminal nuclear localization
signal (NLS).

Molecular Formula : C15 2H2 H8 O5

Molecular Formula : C21H17Na2O14S

Molecular Formula : C20H40N4O10 • x(C2H4O2)

Molecular Formula : C31H63N5O17 (for non-Deuterated)

Molecular Formula : C19 H39 N5 O7 .C10 H20 O10

Molecular Formula : No Data Available

Molecular Formula : C19H38N4O10.x(H2SO4)

Molecular Formula : C149H249N47O42 . x(CH3COOH)

Molecular Formula : C19 H24 O6

Molecular Formula : C19H22O6

Molecular Formula : C19H24O7

Molecular Formula : C213C3H4ClNO2

Molecular Formula : C29 2H8 H23 N7 O . C H4 O3 S

Molecular Formula : C12 D5 H17 N Na O10 S3

Molecular Formula : C20H22D10N6O12S2 • x(NH3)

Molecular Formula : 13C3 H5 N O2

Molecular Formula : C32H49NNa2O11

Molecular Formula : C26H36D5NNa2O8S

Molecular Formula : C4 H11 N O . H Cl

Molecular Formula : C19 D3 H25 O11

Molecular Formula : C513C5H11N5NaO7P

Molecular Formula : C913CH12N315N2O7P

Molecular Formula : C20 H20 O14

Molecular Formula : C21 D6 H17 N O5